-+ 0.00%
-+ 0.00%
-+ 0.00%

China Resources Pharmaceutical Unit Secures Approval for RMB 10 Billion Corporate Bond Issuance

PUBT·11/16/2026 11:27:01
China Resources Pharmaceutical Unit Secures Approval for RMB 10 Billion Corporate Bond Issuance
  • China Resources Pharmaceutical subsidiary CR Pharmaceutical Commercial secured registration for RMB 10 billion of debt financing instruments in China.
  • The subsidiary also obtained registration approval for RMB 10 billion of corporate bonds for qualified investors in China.
  • Both registrations permit issuance in tranches over two years from their respective issue dates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261116-12414653), on November 16, 2026, and is solely responsible for the information contained therein.